Loading data for NNNN — first visit, this takes a few seconds.

Anbio Biotechnology (NNNN)

NasdaqGM: NNNN · Precio en tiempo real · USD

6.60

-0.25 (-3.65%)

Al cierre: Sep 04, 2026, 8:00 PM

6.54

+0.00%

Fuera de horario: 7:30 PM

Alerta

Alert

El precio, las cifras principales y las últimas noticias, en un solo sitio.

No hay datos disponibles

Precio de compra	11.55
Capitalización de mercado	287M
Ingresos (TTM)	8.65M
Beneficio neto (TTM)	6.4M
	0.00
	0.15
	43.6
	n/a
P/B (TTM)	9.52
P/S (TTM)	33.20
Fecha de resultados	n/a

Precio de venta	9.89
Volumen	226,359
Volumen medio (20D)	99,252
Abierto	6.84
Anterior Cerrar	6.85
Rango del día	6.30 - 6.93
Rango de 52 semanas	6.28 - 51.33
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	n/a

Acerca de NNNN

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over...

[Leer más]

Industria Medical Instruments & Supplies

Sector Healthcare

IPO Fecha Feb 19, 2025

Empleados 27

Bolsa de Valores NasdaqGM

Símbolo bursátil NNNN

Sitio web https://www.anbiobiotechnology.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Anbio Biotechnology fueron 8.65M, un aumento de 5.64% en comparación con 8.19M del año anterior. Las ganancias fueron 6.4M, un aumento de 169.86%.

Estados financieros

Sorpresa de resultados

Anbio Biotechnology ha publicado sus resultados trimestrales en Invalid Date:

Ingresos de n/a falla las estimaciones por $0, con NaN% Crecimiento interanual.
EPS de falla las estimaciones por , con NaN% Crecimiento interanual.

Por qué se movió el precio

Noticias

3 meses hace · Simply Wall St.

US Undiscovered Gems To Watch In May 2026

The United States market has shown robust performance recently, climbing 1.8% in the last week and up 28% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In ...

3 meses hace · Simply Wall St.

Discover 3 Undiscovered Gems in the US Market

The United States market has experienced a notable rise, climbing 1.8% in the last week and up 28% over the past year, with earnings projected to grow by 17% annually. In such a robust environment, id...

3 meses hace · Simply Wall St.

Uncovering US Market's 3 Undiscovered Gems With Potential

The United States market has experienced a notable rise, with a 1.3% increase over the last week and a substantial 28% gain in the past year, while earnings are projected to grow by 17% annually in th...

3 meses hace · Simply Wall St.

Discovering US Undiscovered Gems In May 2026

Over the last 7 days, the United States market has remained flat, yet it has seen a remarkable increase of 27% over the past year with earnings forecasted to grow by 17% annually. In such a dynamic en...

3 meses hace · Simply Wall St.

Undiscovered Gems in the US Market May 2026

In the last week, the United States market has stayed flat despite being up 27% over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying stocks with stron...

Página 1 de 2

Anbio Biotechnology (NNNN)